Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:969-977
Published online before print March 26, 2009, doi: 10.1161/CIRCRESAHA.108.192856
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/8/969    most recent
CIRCRESAHA.108.192856v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwon, S.-M.
Right arrow Articles by Asahara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwon, S.-M.
Right arrow Articles by Asahara, T.
Related Collections
Right arrow Angiogenesis
Right arrow Other Vascular biology
(Circulation Research. 2009;104:969.)
© 2009 American Heart Association, Inc.


Molecular Medicine

Pivotal Role of Lnk Adaptor Protein in Endothelial Progenitor Cell Biology for Vascular Regeneration

Sang-Mo Kwon*, Takahiro Suzuki*, Atsuhiko Kawamoto, Masaaki Ii, Masamichi Eguchi, Hiroshi Akimaru, Mika Wada, Tomoyuki Matsumoto, Haruchika Masuda, Yoshihiro Nakagawa, Hiromi Nishimura, Kenji Kawai, Satoshi Takaki, Takayuki Asahara

From the Departments of Regenerative Medicine Science (S.-M.K., M.E., M.W., H.M., K.K., T.A.) and Ophthalmology (T.S., Y.N.), Tokai University School of Medicine, Isehara; Vascular Regeneration Research Group (S.-M.K., A.K., M.I., H.A., T.M., H.N., T.A.), Institute of Biomedical Research and Innovation, Kobe; and Department of Community Health and Medicine (S.T.), Research Institute, International Medical Center of Japan, Tokyo.

Correspondence to Takayuki Asahara, MD, PhD, Department of Regenerative Medicine Science, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan 259-1193. E-mail asa777{at}is.icc.u-tokai.ac.jp

Despite the fact that endothelial progenitor cells (EPCs) are important for postnatal neovascularization, their origins, differentiation, and modulators are not clear. Here, we demonstrate that Lnk, a negative regulator of hematopoietic stem cell proliferation, controls endothelial commitment of c-kit+/Sca-1+/Lineage (KSL) subpopulations of bone marrow cells. The results of EPC colony–forming assays reveal that small (primitive) EPC colony formation by CD34 KSLs and large (definitive) EPC colony formation by CD34(dim) KSLs are more robust in lnk–/– mice. In hindlimb ischemia, perfusion recovery is augmented in lnk–/– mice through enhanced proliferation and mobilization of EPCs via c-Kit/stem cell factor. We found that Lnk-deficient EPCs are more potent actors than resident cells in hindlimb perfusion recovery and ischemic neovascularization, mainly via the activity of bone marrow-EPCs. Similarly, lnk–/– mice show augmented retinal neovascularization and astrocyte network maturation without an increase in indicators of pathogenic angiogenesis in an in vivo model of retinopathy. Taken together, our results provide strong evidence that Lnk regulates bone marrow-EPC kinetics in vascular regeneration. Selective targeting of Lnk may be a safe and effective strategy to augment therapeutic neovascularization by EPC transplantation.


Key Words: endothelial progenitor cell • lnk • vascular regeneration